Combinatorial treatment of tart cherry extract and essential fatty acids reduces cognitive impairments and inflammation in the mu-p75 saporin-induced mouse model of Alzheimer's disease

Journal of Medicinal Food

Volumn 16, Issue 4, 2013, Pages 288-295

  Matchynski, Jessica J ^a,b   Lowrance, Steven A ^a   Pappas, Colleen ^a   Rossignol, Julien ^a,c   Puckett, Nicole ^a   Sandstrom, Michael ^a   Dunbar, Gary L ^a,c,d  

^a CENTRAL MICHIGAN UNIVERSITY   (United States)

^b Rochester Hospital   (United States)

^c Children's Hospital of Michigan   (United States)

^d Field Neurosciences Institute   (United States)

Author keywords

antioxidant; inflammation; learning; memory; omega 3

Indexed keywords

ANTIOXIDANT; CERISE TOTAL BODY RHYTHM; EMU OIL; ESSENTIAL FATTY ACID; FISH OIL; METHYLCELLULOSE; NORDIC FISH OIL; NUTRACEUTICAL; PLANT EXTRACT; SAPORIN; TART CHERRY EXTRACT; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN PROTECTION; BRAIN TISSUE; CELL LOSS; CELL PROLIFERATION; CHOLINERGIC NERVE CELL; COGNITIVE DEFECT; CONTROLLED STUDY; DEPTH PERCEPTION; DISEASE SEVERITY; DRUG DOSE COMPARISON; EXPERIMENTAL MODEL; FEMALE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MAZE TEST; MICROGLIA; MOTOR PERFORMANCE; MOUSE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; RECOGNITION; ROTAROD TEST; TASK PERFORMANCE;

ALZHEIMER DISEASE; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; BRAIN; COGNITION; COGNITION DISORDERS; DIETARY FATS; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; DROMAIIDAE; DRUG COMBINATIONS; FATTY ACIDS, ESSENTIAL; FEMALE; FISH OILS; INFLAMMATION; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; PHYTOTHERAPY; PLANT EXTRACTS; PRUNUS; RECOGNITION (PSYCHOLOGY); RIBOSOME INACTIVATING PROTEINS, TYPE 1;

MUS;

EID: 84876116844     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2012.0131     Document Type: Article

References (42)

1. Rathmann KL, Conner CS: Alzheimer's disease: Clinical features, pathogenesis, and treatment. Ann Pharmacother 1984; 18:684-691
2. Terry AV Jr, Buccafusco JJ: The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: Recent challenges and their implications for novel drug development. J Pharmacol Exp Ther 2003;306:821-827
3. Zhu X, Su B, Wang X, Smith MA, Perry G: Causes of oxidative stress in Alzheimer disease. Cell Mol Life Sci 2007;64:2202-2210
4. Markesbery WR: Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 1997;23:134-147
5. Seeram NP, Bourquin LD, Nair MG: Degradation products of cyanidin glycosides from tart cherries and their bioactivities. J Agric Food Chem 2001;49:4924-4929
6. Blando F, Gerardi C, Nicoletti I: Sour cherry (Prunus cerasus L) anthocyanins as ingredients for functional foods. J Biomed Biotechnol 2004;2004:253-258
7. Wang H, Nair MG, Strasburg GM, Booren AM, Gray JI: Antioxidant polyphenols from tart cherries (Prunus cerasus). J Agric Food Chem 1999;47:840-844
8. Wang H, Nair MG, Strasburg GM, Booren AM, Gray JI: Novel antioxidant compounds from tart cherries (Prunus cerasus). J Nat Prod 1999;62:86-88
9. Joseph JA, Shukitt-Hale B, Denisova NA, et al.: Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation. J Neurosci 1999;19:8114-8121
10. Zandi PP, Anthony JC, Khachaturian AS, et al.: Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: The Cache County Study. Arch Neurol 2004;61:82-88
11. Perkins AJ, Hendrie HC, Callahan CM, et al.: Association of antioxidants with memory in a multiethnic elderly sample using the Third National Health and Nutrition Examination Survey. Am J Epidemiol 1999;150:37-44
12. Kim DO, Heo HJ, Kim YJ, Yang HS, Lee CY: Sweet and sour cherry phenolics and their protective effects on neuronal cells. J Agric Food Chem 2005;53:9921-9927
13. Wang H, Nair MG, Strasburg GM, et al.: Antioxidant and antiinflammatory activities of anthocyanins and their aglycon, cyanidin, from tart cherries. J Nat Products 1999;62: 294-296
14. Seeram NP, Momin RA, Nair MG, Bourquin LD: Cyclooxygenase inhibitory and antioxidant cyanidin glycosides in cherries and berries. Phytomedicine 2001;8:362-369
15. Lim GP, Yang F, Chu T, et al.: Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J Neurosci 2000;20:5709-5714
16. Lim GP, Yang F, Chu T, et al.: Ibuprofen effects on Alzheimer pathology and Open Field activity in APPsw transgenic mice. Neurobiol Aging 2001;22:983-991
17. Connor WE, Connor SL: The importance of fish and docosahexaenoic acid in Alzheimer disease. Am J Clin Nutr 2007;85: 929-930
18. Haag M: Essential fatty acids and the brain. Can J Psychiatry 2003;48:195-203
19. Morris MC, Evans DA, Bienias JL, et al.: Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol 2003;60:940-946
20. Calon F, Lim GP, Morihara T, et al.: Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer's disease. Eur J Neurosci 2005;22:617-626
21. Calon F, Lim GP, Yang F, et al.: Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron 2004;43:633-645
22. Cole GM, Frautschy SA: Docosahexaenoic acid protects from amyloid and dendritic pathology in an Alzheimer's disease mouse model. Nutr Health 2006;18:249-259
23. Green KN, Martinez-Coria H, Khashwji H, et al.: Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-beta and tau pathology via a mechanism involving presenilin 1 levels. J Neurosci 2007;27:4385-4395
24. Lim GP, Calon F, Morihara T, et al.: A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J Neurosci 2005;25: 3032-3040
25. Oksman M, Iivonen H, Hogyes E, et al.: Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-Amyloid accumulation in APP/PS1 transgenic mice. Neurobiol Dis 2006;23:563-572
26. Berger-Sweeney J, Stearns NA, Murg SL, Floerke-Nashner LR, Lappi DA, Baxter MG: Selective immunolesions of cholinergic neurons in mice: Effects on neuroanatomy, neurochemistry, and behavior. J Neurosci 2001;21:8164-8173
27. Moreau PH, Cosquer B, Jeltsch H, Cassel JC, Mathis C: Neuroanatomical and behavioral effects of a novel version of the cholinergic immunotoxin mu p75-saporin in mice. Hippocampus 2008;18:610-622
28. Nag N, Baxter MG, Berger-Sweeney JE: Efficacy of a murinep75-saporin immunotoxin for selective lesions of basal forebrain cholinergic neurons in mice. Neurosci Lett 2009;452: 247-251
29. Hunter CL, Quintero EM, Gilstrap L, Bhat NR, Granholm AC: Minocycline protects basal forebrain cholinergic neurons from mu p75-saporin immunotoxic lesioning. Eur J Neurosci 2004;19: 3305-3316
30. Lowrance S, Matchynski JJ, Rossignol J, Dekorver N, Sandstrom M, Dunbar G: CXB-909 attenuates cognitive deficits in the mup75 saporing mouse model of Alzheimer's disease. Neurosci Med 2012;3:65-68
31. Dey ND, Boersen AJ, Myers RA, et al.: The novel substituted pyrimidine, KP544, reduces motor deficits in the R6/2 transgenic mouse model of Huntington's disease. Restor Neurol Neurosci 2007;25:485-492
32. Mumby DG, Gaskin S, Glenn MJ, Schramek TE, Lehmann H: Hippocampal damage and exploratory preferences in rats: Memory for objects, places, and contexts. Learn Mem 2002;9:49-57
33. Morris RGM, Garrud P, Rawlins JN, O'Keefe J: Place navigation impaired in rats with hippocampal lesions. Nature 1982;297: 681-683
34. Hammond RS, Tull LE, Stackman RW: On the delay-dependent involvement of the hippocampus in object recognition memory. Neurobiol Learn Mem 2004;82:26-34
35. Lawson TM, Amos N, Bulgen D, Williams BD: Minocyclineinduced lupus: Clinical features and response to rechallenge. Rheumatology (Oxford) 2001;40:329-335
36. Joseph JA, Shukitt-Hale B, Denisova NA, et al.: Long-Term dietary strawberry, spinach, or vitamin E supplementation retards the onset of age-related neuronal signal-Transduction and cognitive behavioral deficits. J Neurosci 1998;18:8047-8055
37. Andres-Lacueva C, Shukitt-Hale B, Galli RL, et al.: Anthocyanins in aged blueberry-fed rats are found centrally and may enhance memory. Nutr Neurosci 2005;8:111-120
38. Ouellet M, Emond V, Chen CT, et al.: Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood-brain barrier: An in situ cerebral perfusion study. Neurochem Int 2009; 55:476-482
39. Grundman M: Vitamin E and Alzheimer disease: The basis for additional clinical trials. Am J Clin Nutr 2000;71:630S-636S.
40. Dai Q, Borenstein AR, Wu Y, Jackson JC, Larson EB: Fruit and vegetable juices and Alzheimer's disease: The Kame Project. Am J Med 2006;119:751-759
41. Freund-Levi Y, Basun H, Cederholm T, et al.: Omega-3 supplementation in mild to moderate Alzheimer's disease: Effects on neuropsychiatric symptoms. Int J Geriatr Psychiatry 2008; 23:161-169
42. Freund-Levi Y, Eriksdotter-Jonhagen M, Cederholm T, et al.: Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: A randomized double-blind trial. Arch Neurol 2006;63:1402-1408